Skip to main content

ADVERTISEMENT

Drug-eluting stent

Original Contribution
10/31/2013

Aleksander Ernst, MD, PhD, Joško Bulum, MD, PhD, Jadranka Šeparović, Hanževački, MD, PhD, Martina Lovrić Benčić, MD, PhD, Maja Strozzi, MD, PhD

Aleksander Ernst, MD, PhD, JosÃåko Bu...
Long-term efficacy and dynamics of systolic and diastolic luminal changes within the bridged segments of coronary arteries after intracoronary stenting with drug-eluting stent in patients with symptomatic myocardial bridging (SMB) in the...
Long-term efficacy and dynamics of systolic and diastolic luminal changes within the bridged segments of coronary arteries after intracoronary stenting with drug-eluting stent in patients with symptomatic myocardial bridging (SMB) in the...
Long-term efficacy and dynamics...
10/31/2013
Journal of Invasive Cardiology
Original Contribution
10/30/2013

Natasza Gilis-Siek, MD1*, Marcin Fijalkowski, MD, PhD1*, Milosz Jaguszewski, MD, PhD2*, Radoslaw Targonski, MD, PhD3, Aneta Strozyk, MD1, Monika Cackowska, MD1, Emilia Masiewicz, MD1, Pawel Skarzynski, MD, PhD1, Slawomir Burakowski, MD, PhD1, Michal Chmielecki, MD1, Lukasz Lewicki, MD, PhD3, Witold Dubaniewicz, MD, PhD3, Marcin Gruchala, MD, PhD1, Dariusz Ciecwierz, MD, PhD1, Andrzej Rynkiewicz, MD, PhD1

Natasza Gilis-Siek, MD1*, Marcin Fija...
We investigate whether drug-eluting stent compared with bare-metal stent implantation improves long-term outcomes after successful recanalization of single chronic total occlusion in patients with stable angina.
We investigate whether drug-eluting stent compared with bare-metal stent implantation improves long-term outcomes after successful recanalization of single chronic total occlusion in patients with stable angina.
We investigate whether...
10/30/2013
Journal of Invasive Cardiology
Letters to the Editor
08/29/2013
Wail Nammas, MD; Authors Reply by Helder Dores and Luís Raposo
Wail Nammas, MD; Authors Reply by Hel...
NULL
NULL
NULL
08/29/2013
Journal of Invasive Cardiology
Original Contribution
08/29/2013

Santo Ferrarello, MD1*, Charis Costopoulos, MD1,2,3*, Azeem Latib, MD1,2, Toru Naganuma, MD1,2, Alessandro Sticchi, MD1, Filippo Figini, MD1,2, Sandeep Basavarajaiah, MD1,2, Mauro Carlino, MD1, Alaide Chieffo, MD1, Matteo Montorfano, MD1, Masanori Kawaguchi, MD1, Charbel Naim, MD1, Francesco Giannini, MD1, Antonio Colombo, MD1,2

Santo Ferrarello, MD1*, Charis Costop...
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the...
08/29/2013
Journal of Invasive Cardiology
Original Contribution
07/30/2013

Saami K. Yazdani, PhD1, Alexander Sheehy2, Masataka Nakano, MD1, Gaku Nakazawa, MD1, Marc Vorpahl, MD1, Fumiyuki Otsuka, MD, PhD1, Rosy S. Donn2, Laura E. Perkins, DVM, PhD2, Charles A. Simonton, MD2, Frank D. Kolodgie, PhD1, Renu Virmani, MD1

Saami K. Yazdani, PhD1, Alexander She...
Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...
Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...
Second-generation DES have...
07/30/2013
Journal of Invasive Cardiology
Original Contribution
07/30/2013

Eulogio García, MD1, Antoni Serra, MD2, José Javier Zueco, MD3, Mariano Larman, MD4, José Ramón Rumoroso, MD5, José Moreu, MD6, Jordi Guarinos, MD7, María Rosario Ortas, MD8, Basaganyas Puigfel, MD9, Adolfo Rincón, MD10, Karagounis Ioannidis, MD11, Núria Piqué, PhD12

Eulogio García, MD1, Antoni Serra, M...
Under routine clinical practice, the implantation of paclitaxel-eluting stents coated with P-5 is associated with favorable clinical outcomes in both the short and long term (2 years) in patients with coronary artery disease.
Under routine clinical practice, the implantation of paclitaxel-eluting stents coated with P-5 is associated with favorable clinical outcomes in both the short and long term (2 years) in patients with coronary artery disease.
Under routine clinical practice,...
07/30/2013
Journal of Invasive Cardiology
Commentary
06/26/2013

Lawrence Rajan, MD and David J. Moliterno, MD

Lawrence Rajan, MD and David J. Molit...
The observations from Dores et al are consistent with prior reports in that the rates of definite stent thrombosis are low and decreasing in recent years. The challenge remains how to afford to study such low frequency events with...
The observations from Dores et al are consistent with prior reports in that the rates of definite stent thrombosis are low and decreasing in recent years. The challenge remains how to afford to study such low frequency events with...
The observations from Dores et...
06/26/2013
Journal of Invasive Cardiology
Original Contribution
04/01/2013

Jose M. de la Torre Hernandez, MD, PhD, Tamara Garcia Camarero, MD, Piedad Lerena, MD, Dae-Hyun Lee, MD, Fermin Sainz Laso, MD, Gonzalo Martin Gorria, MD, Javier Zueco, MD

Jose M. de la Torre Hernandez, MD, Ph...
Recently a new everolimus-eluting stent with a platinum based platform (PtCr-EEs) has been introduced in the market. This study evaluates clinical outcomes with the PtCr-EES compared with the CoCr-EES in an all comers population in a real...
Recently a new everolimus-eluting stent with a platinum based platform (PtCr-EEs) has been introduced in the market. This study evaluates clinical outcomes with the PtCr-EES compared with the CoCr-EES in an all comers population in a real...
Recently a new...
04/01/2013
Journal of Invasive Cardiology
02/27/2013

Aniket Puri, MD, DM, Ramkrishna Saireddy, FRACP, Dougal McClean, FRACP

Aniket Puri, MD, DM, Ramkrishna Saire...
This report describes the case of a 40-year-old patient with simultaneous two-vessel stent thrombosis (left anterior descending and right coronary arteries) 31 months after everolimus-eluting stent implantation.
This report describes the case of a 40-year-old patient with simultaneous two-vessel stent thrombosis (left anterior descending and right coronary arteries) 31 months after everolimus-eluting stent implantation.
This report describes the case...
02/27/2013
Journal of Invasive Cardiology
Original Contribution
02/26/2013

Scott Midwall, MD*, Rajesh V. Swaminathan, MD*, Konstantinos Charitakis, MD, Luke K. Kim, MD, Jonathan Gordin, MD, Ingrid Hriljac, MD, Robert M. Minutello, MD, Geoffrey Bergman, MD, S. Chiu Wong, MD,  Dmitriy N. Feldman, MD

Scott Midwall, MD*, Rajesh V. Swamina...
Patients with PVD undergoing coronary revascularization have high rates of adverse short-term outcomes. However, the long-term clinical outcomes of patients with PVD undergoing PCI in the contemporary drug-eluting stent era have not been well...
Patients with PVD undergoing coronary revascularization have high rates of adverse short-term outcomes. However, the long-term clinical outcomes of patients with PVD undergoing PCI in the contemporary drug-eluting stent era have not been well...
Patients with PVD undergoing...
02/26/2013
Journal of Invasive Cardiology